mTOR inhibitor treatment of pancreatic cancer in a patient With Peutz-Jeghers syndrome

J Clin Oncol. 2011 Feb 20;29(6):e150-3. doi: 10.1200/JCO.2010.32.7825. Epub 2010 Dec 28.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • AMP-Activated Protein Kinase Kinases
  • Antineoplastic Agents / therapeutic use*
  • Base Sequence
  • Everolimus
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / genetics
  • Peutz-Jeghers Syndrome / complications
  • Peutz-Jeghers Syndrome / genetics
  • Protein Serine-Threonine Kinases / genetics
  • Sirolimus / analogs & derivatives*
  • Sirolimus / therapeutic use
  • TOR Serine-Threonine Kinases / antagonists & inhibitors*

Substances

  • Antineoplastic Agents
  • Everolimus
  • MTOR protein, human
  • Protein Serine-Threonine Kinases
  • STK11 protein, human
  • TOR Serine-Threonine Kinases
  • AMP-Activated Protein Kinase Kinases
  • Sirolimus